The U.S. Food and Drug Administration has approved Merck’s Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in…
Continue Reading
News Source: medicalxpress.com
FDA approves once-daily Idvynso tablet for treating HIV
Leave a Reply